Related Experiment Video
Updated: Oct 6, 2025
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.0K
Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?
Lauren A Quinn1, Sunaya H Hirani2, Thomas C Williams3,4,5
1Queens University Belfast School of Medicine Dentistry and Biomedical Sciences, Belfast, UK.
Breathe (Sheffield, England)
|January 17, 2022
Insights
Immunoprophylaxis against RSV may protect premature infants with bronchopulmonary dysplasia from future respiratory issues. Further research is needed to confirm the benefits of this intervention for vulnerable infants.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Infectious Disease Immunology
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants, increasing their susceptibility to respiratory infections.
- Respiratory Syncytial Virus (RSV) is a common cause of severe lower respiratory tract infections in infants, particularly those with BPD.
- Immunoprophylaxis, such as palivizumab, is used to prevent RSV infections, but its efficacy in protecting infants with BPD from long-term respiratory sequelae is not fully established.
Discussion:
- The biological plausibility of RSV immunoprophylaxis protecting against future respiratory problems in preterm infants with BPD exists due to the inflammatory and structural lung damage caused by RSV infections.
- However, the clinical evidence supporting this protective effect against chronic respiratory issues, beyond acute RSV illness, remains uncertain.
- Individual infant factors, severity of BPD, and the specific immunoprophylaxis regimen may influence outcomes.
Key Insights:
- Current evidence is insufficient to definitively conclude whether RSV immunoprophylaxis prevents long-term respiratory problems in preterm infants with BPD.
- A potential benefit is biologically plausible, suggesting that reducing RSV burden might mitigate further lung injury in these vulnerable infants.
- More targeted research is required to elucidate the precise role and effectiveness of immunoprophylaxis in this specific population.
Outlook:
- Future studies should focus on long-term follow-up of preterm infants with BPD who receive RSV immunoprophylaxis to assess chronic respiratory outcomes.
- Investigating biomarkers and specific infant characteristics could help identify subgroups most likely to benefit from immunoprophylaxis.
- Clarifying the role of RSV prevention in managing BPD is crucial for optimizing respiratory care in extremely preterm infants.
Abstract:
It is uncertain whether immunoprophylaxis against RSV protects preterm babies with BPD against future respiratory problems. It is biologically plausible that it does, at least in some infants. https://bit.ly/3ikzwZD.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
455
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
455
01:23Mechanical Ventilation III: Noninvasive Ventilation
305
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
305
01:30Pneumonia V: Nursing management and Prevention
2.6K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.6K
01:30Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:28Pneumonia IV: Management
491
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
491